Predictors of anti-vascular endothelial growth factor treatment responses in macular edema following central vein occlusion

被引：1
|
作者：
Huang Peirong [1 ]
Song Zhengyu [2 ]
Sun Xiaodong [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200080, Peoples R China
[2] Shanghai Jiao Tong Univ, Eye Res Inst, Shanghai Key Lab Fundus Dis, Shanghai 200080, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2014年 / 127卷 / 16期
基金：
中国国家自然科学基金;
关键词：
retinal vein occlusion; macular edema; vascular endothelial growth factor; visual acuity; OPTICAL COHERENCE TOMOGRAPHY; RANIBIZUMAB; BEVACIZUMAB; INJECTION; SECONDARY; OUTCOMES; NEOVASCULARIZATION; PREVALENCE; MANAGEMENT; DISORDERS;
D O I：
10.3760/cma.j.issn.0366-6999.20140006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：3019 / 3023
页数：5
相关论文
共 50 条
  • [41] Anti-vascular endothelial growth factor dosing frequency and visual outcomes in macular oedema following branch retinal vein occlusion
    Modi, Yasha S.
    Goduni, Lediana
    Moini, Hadi
    Gibson, Andrea
    Boucher, Nick
    Lucas, Genevieve
    Dhoot, Dilsher S.
    EYE, 2023, 37 (16) : 3423 - 3428
  • [42] Audit on treatment of macular oedema in central retinal vein occlusion (CRVO) with anti-vascular endothelial growth factor (anti-VEGF) at The Western Eye Hospital
    Quijano, C.
    Theodorou, O.
    Younis, S.
    EYE, 2017, 31 : S15 - S16
  • [43] Consequences of anti-vascular endothelial growth factor treatment lapse in patients with retinal vein occlusion
    Liu, Jessica C.
    Alsaloum, Peter
    Iyer, Amogh I.
    Kaiser, Peter M.
    Singh, Rishi P.
    EYE, 2023, 37 (03) : 453 - 458
  • [44] Consequences of anti-vascular endothelial growth factor treatment lapse in patients with retinal vein occlusion
    Jessica C. Liu
    Peter Alsaloum
    Amogh I. Iyer
    Peter M. Kaiser
    Rishi P. Singh
    Eye, 2023, 37 : 453 - 458
  • [45] The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes
    Rao, Jie
    Wu, Na
    Qu, Xiaoyong
    Hu, Yuxiang
    Wu, Yajun
    Cheng, Yi
    Yan, Li
    Huang, Hui
    Li, Siyu
    Shi, Ling
    Wu, Xiaorong
    OPHTHALMIC RESEARCH, 2021, 64 (02) : 237 - 245
  • [46] Anti-VEGF(anti-vascular endothelial growth factor)-Therapie bei Zentralvenenverschluss in der StillzeitAnti-VEGF (anti-vascular endothelial growth factor) treatment for central vein occlusion during breastfeeding
    S. Groselli
    L. Bechstein
    K. Gabka
    M. Ulbig
    Die Ophthalmologie, 2023, 120 : 751 - 754
  • [47] Characteristics of Patients Who Drop Out of Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Associated with Branch Retinal Vein Occlusion
    Kawakami, Setsuko
    Wakabayashi, Yoshihiro
    Watanabe, Yoko
    Umazume, Kazuhiko
    Yamamoto, Kaori
    Goto, Hiroshi
    JOURNAL OF OPHTHALMOLOGY, 2024, 2024
  • [48] Fluctuations in Macular Thickness in Patients with Retinal Vein Occlusion Treated with Anti-Vascular Endothelial Growth Factor Agents
    Chen, Andrew X.
    Greenlee, Tyler E.
    Conti, Thais F.
    Briskin, Isaac N.
    Singh, Rishi P.
    OPHTHALMOLOGY RETINA, 2020, 4 (12): : 1158 - 1169
  • [49] The Therapeutic Effect of Anti-vascular Endothelial Growth Factor on Central Retinal Vein Occlusion-induced Macular Edema at Different Ages and its Relationship with OCT Characteristics
    Li, Man
    Ren, Yonggang
    Shan, Wuqiang
    Liao, Zhoupeng
    Zhang, Xiaoqiang
    Sun, Yaru
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 (07): : 1487 - 1492
  • [50] Treatment of cystoid macular edema secondary to infectious uveitis with anti-vascular endothelial growth factor agents
    Ogden, Tyler
    Sandhu, Harpal
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
12345